Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
57
LGND Quote, Financials, Valuation and Earnings
Last price:
$137.75
Seasonality move
:
-3.29%
Day range:
$129.47 - $137.84
52-week range:
$90.29 - $137.84
Dividend yield:
0%
P/E ratio:
46.13x
P/S ratio:
14.14x
P/B ratio:
3.34x
Volume:
371.3K
Avg. volume:
151.7K
1-year change:
36.11%
Market cap:
$2.7B
Revenue:
$167.1M
EPS (TTM):
-$7.12
Earnings Data
Next earnings date for LGND
Aug 06
2025
Most recent earnings per share
-$2.21
Missed by $3.42
(May 8/2025)
Consensus Estimate
$1.21
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LGND Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $49.6M | -- | -- | $1.59 | -- |
| 08/06/2025 | Q2 | $43.9M | -- | -- | $1.42 | -- |
| 05/08/2025 | Q1 | $37.8M | $45.3M | -$2.21 | $1.21 | -$3.42 |
| 02/27/2025 | Q4 | $39M | $42.8M | -$1.64 | $1.19 | -$2.83 |
| 11/07/2024 | Q3 | $40.6M | $51.8M | -$0.39 | $1.35 | -$1.74 |
| 08/06/2024 | Q2 | $34.3M | $41.5M | -$2.88 | $1.06 | -$3.94 |
| 05/07/2024 | Q1 | $27.9M | $31M | $4.75 | $0.83 | $3.92 |
| 02/27/2024 | Q4 | $25.6M | $28.1M | $1.03 | $0.66 | $0.37 |
| 11/08/2023 | Q3 | -- | -- | -$0.59 | $0.62 | -$1.21 |
| 08/08/2023 | Q2 | -- | -- | $0.13 | $0.66 | -$0.53 |
| 05/04/2023 | Q1 | -- | -- | $2.33 | $0.89 | $1.44 |
| 02/22/2023 | Q4 | -- | -- | -$1.04 | $1.12 | -$2.16 |
| 11/07/2022 | Q3 | -- | -- | $0.02 | $0.43 | -$0.41 |
| 08/08/2022 | Q2 | -- | -- | -$0.05 | $0.43 | -$0.48 |
| 05/04/2022 | Q1 | -- | -- | -$0.91 | $0.66 | -$1.57 |
| 02/17/2022 | Q4 | -- | -- | -$0.30 | $1.37 | -$1.67 |
| 11/09/2021 | Q3 | -- | -- | $0.80 | $1.04 | -$0.24 |
| 07/29/2021 | Q2 | -- | -- | $1.79 | $1.36 | $0.43 |
| 05/03/2021 | Q1 | -- | -- | $1.05 | $1.13 | -$0.08 |
| 02/03/2021 | Q4 | -- | -- | $0.35 | $1.09 | -$0.74 |
| 10/30/2020 | Q3 | -- | -- | -$0.42 | $0.98 | -$1.40 |
| 08/03/2020 | Q2 | -- | -- | $1.32 | $0.76 | $0.56 |
| 05/06/2020 | Q1 | -- | -- | -$1.46 | $0.66 | -$2.12 |
| 02/06/2020 | Q4 | -- | -- | -$0.43 | $0.65 | -$1.08 |
| 11/05/2019 | Q3 | -- | -- | -$0.81 | $0.62 | -$1.43 |
| 07/30/2019 | Q2 | -- | -- | -$0.74 | $0.55 | -$1.29 |
| 05/02/2019 | Q1 | -- | -- | $31.32 | $15.45 | $15.87 |
| 02/07/2019 | Q4 | -- | -- | -$2.02 | $1.22 | -$3.24 |
| 11/08/2018 | Q3 | -- | -- | $2.80 | $1.03 | $1.77 |
| 08/06/2018 | Q2 | -- | -- | $2.99 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | $1.83 | -- | -- |
| 02/21/2018 | Q4 | -- | -- | -$0.33 | -- | -- |
| 11/09/2017 | Q3 | -- | -- | $0.36 | -- | -- |
| 08/07/2017 | Q2 | -- | -- | $0.26 | -- | -- |
| 05/09/2017 | Q1 | -- | -- | $0.22 | -- | -- |
| 02/23/2017 | Q4 | -- | -- | -$0.15 | -- | -- |
| 11/03/2016 | Q3 | -- | -- | $0.05 | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -$0.30 | -- | -- |
| 05/04/2016 | Q1 | -- | -- | $0.30 | -- | -- |
| 02/10/2016 | Q4 | -- | -- | $0.29 | -- | -- |
| 11/09/2015 | Q3 | -- | -- | $9.28 | -- | -- |
Ligand Pharmaceuticals Earnings Questions
-
How Much did Ligand Pharmaceuticals Generate in Revenue Last Quarter?
Ligand Pharmaceuticals reported $45.3M worth of top line sales in its most recent quarter.
-
Did Ligand Pharmaceuticals Beat Earnings Last Quarter?
Ligand Pharmaceuticals announced earnings per share of -$2.21 which represents a miss of analyst forecast a $1.21 per share.
-
Is Ligand Pharmaceuticals Profitable?
Ligand Pharmaceuticals reported $40.5M that represents $2.11 per share over the last quarter.
-
What is the Analyst Consensus for Ligand Pharmaceuticals EPS Next Year?
Ligand Pharmaceuticals's earnings are forecast to grow from -$0.22 per share to $5.66 per share next year representing an increase of 92.38%.
-
When is Ligand Pharmaceuticals's Earnings Date?
Ligand Pharmaceuticals's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
